June 4, 2026 · Form 4 insider transaction
Aryeh Jason bought 25,907 shares of Lifecore Biomedical, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.; Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).